Sedana Medical Past Earnings Performance
Past criteria checks 0/6
Sedana Medical's earnings have been declining at an average annual rate of -19.4%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 10.6% per year.
Key information
-19.4%
Earnings growth rate
-17.1%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 10.6% |
| Return on equity | -6.0% |
| Net Margin | -32.9% |
| Next Earnings Update | 13 Feb 2025 |
Recent past performance updates
Recent updates
There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 26% Price Jump
Dec 12
kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results
Oct 28Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues
Oct 25After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar
Jun 07Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Apr 28Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
Mar 16Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking
Dec 21We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely
Oct 29Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans
Jul 12Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts
May 01We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely
Feb 17Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be
Jan 20Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
Oct 05Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth
Jul 05Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates
May 03Revenue & Expenses Breakdown
How Sedana Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 174 | -57 | 155 | 21 |
| 30 Jun 24 | 169 | -41 | 154 | 21 |
| 31 Mar 24 | 165 | -23 | 154 | 21 |
| 31 Dec 23 | 154 | -60 | 155 | 21 |
| 30 Sep 23 | 145 | -57 | 160 | 20 |
| 30 Jun 23 | 137 | -58 | 169 | 20 |
| 31 Mar 23 | 127 | -71 | 170 | 20 |
| 31 Dec 22 | 123 | -74 | 170 | 20 |
| 30 Sep 22 | 133 | -54 | 171 | 21 |
| 30 Jun 22 | 135 | -62 | 156 | 21 |
| 31 Mar 22 | 148 | -68 | 153 | 21 |
| 31 Dec 21 | 159 | -58 | 148 | 20 |
| 30 Sep 21 | 159 | -53 | 136 | 16 |
| 30 Jun 21 | 152 | -51 | 128 | 13 |
| 31 Mar 21 | 153 | -38 | 114 | 11 |
| 31 Dec 20 | 142 | -27 | 102 | 8 |
| 30 Sep 20 | 116 | -22 | 78 | 13 |
| 30 Jun 20 | 111 | -14 | 72 | 11 |
| 31 Mar 20 | 88 | -12 | 63 | 8 |
| 31 Dec 19 | 72 | -16 | 56 | 7 |
| 30 Sep 19 | 67 | -13 | 61 | 0 |
| 30 Jun 19 | 63 | -11 | 55 | 0 |
| 31 Mar 19 | 60 | -10 | 51 | 0 |
| 31 Dec 18 | 58 | -7 | 47 | 0 |
| 30 Sep 18 | 53 | -3 | 43 | 0 |
| 30 Jun 18 | 51 | -4 | 41 | 0 |
| 31 Mar 18 | 47 | -3 | 37 | 0 |
| 31 Dec 17 | 42 | -4 | 32 | 0 |
| 30 Sep 17 | 41 | -3 | 30 | 0 |
| 30 Jun 17 | 39 | 0 | 28 | 0 |
| 31 Mar 17 | 36 | 0 | 24 | 0 |
| 31 Dec 16 | 34 | 1 | 22 | 0 |
| 31 Dec 15 | 28 | -1 | 18 | 0 |
Quality Earnings: SEDANA is currently unprofitable.
Growing Profit Margin: SEDANA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SEDANA is unprofitable, and losses have increased over the past 5 years at a rate of 19.4% per year.
Accelerating Growth: Unable to compare SEDANA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SEDANA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: SEDANA has a negative Return on Equity (-6.03%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 09:45 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sedana Medical AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Östling | Pareto Securities |
| Filip Wiberg | Pareto Securities |
| Oscar Bergman | Redeye |